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Abstract
Background: Upper respiratory tract infections (URTIs) are among the most frequent reasons for physician office visits
in paediatrics. Despite their predominant viral aetiology, URTIs continue to be treated with antimicrobials. We explored
general practitioners' (GPs) prescribing behaviour for antimicrobials in children (≤ 16 years) with URTIs in Trinidad, using
the guidelines from the Centers for Disease Control and Prevention (CDC) as a reference.
Methods: A cross-sectional study was conducted on 92 consenting GPs from the 109 contacted in Central and East
Trinidad, between January to June 2003. Using a pilot-tested questionnaire, GPs identified the 5 most frequent URTIs
they see in office and reported on their antimicrobial prescribing practices for these URTIs to trained research students.
Results: The 5 most frequent URTIs presenting in children in general practice, are the common cold, pharyngitis,
tonsillitis, sinusitis and acute otitis media (AOM) in rank order. GPs prescribe at least 25 different antibiotics for these
URTIs with significant associations for amoxicillin, co-amoxiclav, cefaclor, cefuroxime, erythromycin, clarithromycin and
azithromycin (p < 0.001). Amoxicillin alone or with clavulanate was the most frequently prescribed antibiotic for all
URTIs. Prescribing variations from the CDC recommendations were observed for all URTIs except for AOM (50%), the
most common condition for antibiotics. Doctors practicing for >30 years were more likely to prescribe antibiotics for
the common cold (p = 0.014). Severity (95.7%) and duration of illness (82.5%) influenced doctors' prescribing and over
prescribing in general practice was attributed to parent demands (75%) and concern for secondary bacterial infections
(70%). Physicians do not request laboratory investigations primarily because they are unnecessary (86%) and the waiting
time for results is too long (51%).
Conclusions: Antibiotics are over prescribed for paediatric URTIs in Trinidad and amoxicillin with co-amoxiclav were
preferentially prescribed. Except for AOM, GPs' prescribing varied from the CDC guidelines for drug and duration.
Physicians recognise antibiotics are overused and consider parents expecting antibiotics and a concern for secondary
bacterial infections are prescribing pressures. Guidelines to manage URTIs, ongoing surveillance programs for antibiotic
resistance, public health education on non-antibiotic strategies, and postgraduate education for rational pharmacotherapy
in general practice would decrease inappropriate antibiotic use in URTIs.
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Respiratory tract infections are among the most frequently
encountered clinical conditions and URTIs are one of the
most common reasons for paediatric consultations in pri-
mary health care [1,2]. Children in developing countries
suffer an annual average of six URTIs [3], with a high inci-
dence in the first 7 years of life, which are termed the
"catarrhal" stage [4]. These infections impose a burden on
the health care system and are a major reason for absen-
teeism from school and work by children and parents
respectively [5]].
Antimicrobials are the second leading therapeutic drug
category office based physicians prescribe. Even though
current evidence does not warrant their routine use in
upper respiratory tract infections [6,7], their injudicious
use in family practice in the United States revealed 79% of
prescriptions were unnecessary according to the CDC
guidelines [8]. The pandemic increase in multiple antimi-
crobial-resistant strains of Streptococcus pneumoniae, Hae-
mophilus influenzae and Moraxella catarrhalis [9,10] the
major pathogens of otitis media and sinusitis [11] has
been attributed to irrational prescribing, fuelling the
move to reduce unnecessary antimicrobial use. Despite a
viral aetiology antimicrobials continue to be accepted
treatment for 50%-70% of patients seeking medical care
for URTIs [12]. A 1998 report from the United States esti-
mated 6.5 million prescriptions annually (paediatric use
was 12%) were for URTIs or the common cold and chil-
dren were a target for reduction of unnecessary antimicro-
bial use [13]. Antimicrobial misuse or overuse promotes
public perception that these drugs are preferred treatment
for URTIs, encourages patient demand and promotes an
increased pool of resistant bacteria. The CDC in collabo-
ration with the American Academy of Paediatrics (AAP)
and the American Academy of Family Physicians (AAFP),
recommend stringent diagnostic criteria for URTIs to
avoid misdiagnosis and inappropriate antibiotic prescrip-
tions [14]. Family physicians manage URTIs with consid-
erable variation [15] and we undertook this study to
provide insight into this variation in Trinidad, since there
is no information on prescribing patterns in general prac-
tice in Trinidad or the Caribbean. We explored physician
behaviour of antimicrobial prescribing for URTIs in chil-
dren, and practice variations based on the CDC principles
of judicious antibiotic use [16,17].
Methods
A cross-sectional survey was conducted between January
to June 2003 on office based GPs listed in the Trinidad
and Tobago Medical Association. The Association has four
branches with approximately 270 subscribing members in
Trinidad. We approached doctors in Central and East
Trinidad, from the respective branches of the Trinidad and
Tobago Medical Association. A "child" was defined as a
person sixteen years or younger and a "general practi-
tioner" was a doctor with a practice not confined to any
particular specialty of medicine besides family practice.
The Ethics Committee of the Faculty of Medical Sciences,
The University of the West Indies approved the study. Spe-
cialists, consultants and doctors working in primary
health care in the public sector were excluded. Prescribing
for patients who were immuno-compromised, malnour-
ished, infected by laboratory-proven resistant strains of
pathogens and/or who suffered from chronic respiratory
tract disease was not investigated. Letters were mailed to
doctors followed by a telephone call, inviting their partic-
ipation. Student researchers were trained to ask questions
and practiced among themselves to ensure consistency in
administering the pilot-tested questionnaire. Two
researchers interviewed physicians who identified and
ranked the five most common URTIs in their practice.
Practice variations in the management of URTIs were
observed for the prescribed antimicrobials of choice, the
duration of administration for each drug for each of the
identified URTIs, and factors that could influence the phy-
sician's choice of antimicrobial agent. Physicians identi-
fied three characteristic signs and symptoms for each
URTI, and reasons which they believed contributed to
antimicrobial over prescribing for paediatric URTIs in
general practice.
Data were analysed using the Statistical Program for Social
Sciences (SPSS; Chicago, Illinois, version 9.0). Differences
in categorical data were analysed using Chi-square tests,
and p values < 0.05 were considered statistically
significant.
Results
Of 109 listed GPs, 92 (response rate 84.4%) consented to
participate; and representation from Central and East
Trinidad was 40.2% (37) and 59.8% (55) respectively.
There were 81 (88%) male and 11 (12%) female physi-
cians and the doctors' mean age was 52.55 years (SE= ±
1.34). Approximately a quarter of the sample (24, 26.1%)
had > 30 years of practice, 38 (41.3%) doctors were prac-
ticing for < 20 years, and 30 (32.6%) had between 20–30
years of practice. There were 51 (54.4%) graduates of the
University of the West Indies and 41 (45.6%) doctors
were trained abroad.
In rank order, physicians see the common cold, pharyngi-
tis, tonsillitis, sinusitis and AOM in their office practice.
All but one doctor (91, 98.9%) (a naturopath) would pre-
scribe antimicrobials for at least one of the five listed
URTIs and 5 GPs (5.4%) said antimicrobials do not mod-
ify the course of URTIs GPs recommend at least 25 differ-
ent antimicrobials to treat the 5 investigated URTIs in
children. Prescribing was highest for AOM and least for
the common cold (Table 1) and amoxicillin alone or withPage 2 of 8
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bial. Among the cephalosporins (cefaclor, cefuroxime,
cefadroxil, cefalexin,), cefuroxime was the most fre-
quently recommended. Several macrolides (erythromy-
cin, josamycin, clarithromycin, roxithromycin) were
prescribed, but azithromycin was preferred for all URTIs.
Quinolones and tetracylines were seldom prescribed (<9,
9.8%), except for sinusitis by 13 (14.1%) and 12 (13%)
GPs respectively. Doctors practicing for > 30 years were
more likely to prescribe antibiotics for the common cold
(p = 0.014). With the exception of azithromycin, doctors
would prescribe antibiotics for between 5–7 days for all
the URTIs. (Fig 1. Number and duration of antimicrobial
prescriptions made for each URTI). For AOM doctors' pre-
scriptions were in approximately equivalent proportions
for durations of 5–7 days or 10 days, though the CDC rec-
ommends antibiotics for 7 days for this condition.
Significant associations were found between the 5 investi-
gated URTIs and prescribed antimicrobials (p < 0.001)
(Table 2). Amoxicillin was most frequently recommended
for pharyngitis and tonsillitis (47, 51.6% each) and at
least 36 (39.6%) GPs prescribed it for both conditions.
Erythromycin (21, 23%) and azithromycin (27, 29.7%)
were also prescribed for pharyngitis and tonsillitis respec-
tively. Amoxicillin/clavulanate (55, 60.4%), azithromy-
cin, cefaclor (each 29, 29.7%) and clarithromycin (19,
20.8%) were recommended for AOM, and for sinusitis
physicians preferentially prescribed cefuroxime (20, 22%)
and clarithromycin (19, 20.8%). Sixteen (17.5%) GPs
prescribed azithromycin for both tonsillitis and AOM and
12 (13%) prescribed clarithromycin for both sinusitis and
AOM. Fever was one of the three cardinal signs/symp-
toms, physicians consistently associated with all 5 URTIs
(Table 3).
Doctors reported their prescribing was influenced by the
severity of illness (88, 95.7%), duration of infection (76,
82.6%), suspected secondary bacterial infection (64,
69.6%), cost of treatment (63, 68.5%), past clinical expe-
rience (56, 60.9%), ease of drug administration (52,
56.5%), drug allergy (49, 53.3%) and medication taste
(28, 30.4%). Very few GPs said they felt pressured to pre-
scribe by pharmaceutical companies (9, 9.8%), or par-
ents/guardians (7, 7.6%). Nevertheless, doctors (77,
83.7%) admitted antimicrobials were over-prescribed in
general practice and most (86, 93.5%) believed parents/
guardians have misconceptions about antibiotics and
associate recovery with antimicrobials. Interestingly phy-
sicians' reported personal practices were at odds with cited
reasons they offered for antibiotic over-prescription and
75% agreed demands of worried parents do increase anti-
biotic prescribing rates in general practice. (Figure 2.
Reasons physicians offered for antimicrobial overpre-
scription in general practice). Twenty-seven (29.3%) phy-
sicians stated community pharmacists dispense
antibiotics over-the-counter and are responsible for their
overuse in the community.
All doctors advised patients on the prescribed duration of
treatment, but 68 (73.9%) were of the opinion that the
general population was unaware of the importance of
complying with this instruction. Just 11 (12%) doctors
would request laboratory tests before prescribing antimi-
crobials. Seventy of the 80 (87.5%) doctors not requesting
laboratory investigations considered them unnecessary,
10 (12.5%) would not request them even if they thought
the tests necessary and 27 physicians (30%) felt a clinical
diagnosis was sufficient. About half (41, 51.3%) the doc-
tors said laboratory tests were futile because of the long
waiting period for results. The cost of tests (28, 35%) and
the unavailability of adequate laboratory facilities (24,
30%) also discouraged physicians from requesting these
investigations.
Table 1: Percentage of doctors prescribing antimicrobials for the URTIs.
Antimicrobial Pharyngitis (n = 81) Tonsillitis (n = 89) Common cold (n = 21) Sinusitis (n = 87) Otitis media (n = 91)
Penicillins 70 (86.4) 78 (87.6) 19 (90.0) 61 (70.1) 70 (76.9)
Ampicillin, amoxicillin 57 (70.3) 58 (65.2) 17 (80.0) 25 (28.7) 30 (33.0)
Co-amoxiclav 37 (45.7) 51 (57.3) 4 (20.0) 32 (52.9) 55 (60.4)
Macrolides 48 (59.3) 53 (59.6) 7 (35.0) 46 (52.9) 50 (54.9)
Erythromycin & derivatives 46 (56.7) 45 (50.5) 6 (30.0) 36 (41.3) 35 (38.5)
Azithromycin 22 (27.2) 27 (30.3) 2 (10.0) 22 (25.3) 27 (29.7)
Cephalosporins 37 (45.7) 44 (49.4) 6 (30.0) 38 (43.7) 43 (47.3)
1st generation 9 (11.1) 13 (14.6) 2 (10.0) 6 (6.9) 8 (8.8)
2nd generation 33 (40.7) 37 (41.6) 4 (20.0) 40 (46.0) 43 (47.3)
Other 14 (17.3) 11 (12.4) 4 (20.0) 28 (32.2) 13 (14.3)
Quinolones 8 (9.9) 8 (9.0) 3 (14.3) 12 (13.8) 7 (7.7)
Tetracyclines 1 (1.2) 0 (0.0) 1 (4.8) 13 (14.9) 0 (0.0)
* Doctors prescribed more than one antimicrobial for each URTIPage 3 of 8
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gly or in various combinations and included antipyretics,
analgesics, antihistamines, decongestants, antitussives,
expectorants and mucolytic agents. Supportive therapy
comprised fluids, rest, vitamins, tepid sponging, dietary
recommendations, steam inhalation, gargling and keep-
ing warm.
Discussion
Paediatric URTIs in general practice in Trinidad are in rank
order, the common cold, pharyngitis, tonsillitis, sinusitis
and AOM. In Trinidad as in the USA, AOM is the leading
URTI for antimicrobial prescriptions [18]. Amoxicillin
alone or with clavulanate was the preferred drug for all
URTIs and penicillin V was never recommended. In New
Zealand, GPs also prescribed amoxicillin and amoxicillin-
clavulanate most frequently to treat URTIs. [19]. Unneces-
sary use of amoxicillin and co-amoxiclav can increase the
risk of selective pressure and colonisation with resistant
organisms.
In the United States, AOM, acute sinusitis, bronchitis,
pharyngitis and non-specific URTIs (common colds)
account for most antibiotic use in paediatric outpatients
Number and duration of antimicrobial prescriptions doctors made for each URTIFigur  1
Number and duration of antimicrobial prescriptions doctors made for each URTI • Doctors prescribed more than one antimi-
crobial for each URTI
Table 2: Associations (p < 0.001) between prescribed antimicrobials and URTIs
Antimicrobial URTI No. (%) doctors prescribing (n = 91)
Amoxicillin Pharyngitis 47 (51.6)
Tonsillitis 47 (51.6)
Amoxicillin/clavulanate AOM 55 (60.4)
Azithromycin AOM 27 (29.7)
Tonsillitis 27 (29.7)
Cefaclor AOM 27 (29.7)
Cefuroxime Sinusitis 20 (22)
Clarithromycin Sinusitis 19 (20.8)
AOM 19 (20.8)
Erythromycin Pharyngitis 21 (23)Page 4 of 8
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AOM and least for the common cold, a pattern observed
in Turkey [20] and Scandinavia [21]. The common cold is
never an indication for antibiotic treatment and its natu-
ral history suggests mucopurulent rhinitis or cough for
even upto 2 weeks does not necessarily point to bacterial
infection [17]. Antibiotic treatment is beneficial to chil-
dren with this syndrome only if symptoms persist for 10–
14 days without improvement [22]. Several (70.3%) of
our participating doctors were concerned about secondary
bacterial infection, and we speculate high amoxicillin and
co-amoxiclav prescribing represents an anxiety to prevent
Table 3: The three characteristic signs and symptoms doctors associate with URTIs
URTI Signs and Symptoms No. (%) of Doctors n = 92
Pharyngitis Sore throat / pain on swallowing 82 (89.1)
Fever 75 (81.5)
Hyperaemic pharynx 65 (70.7)
Tonsillitis Fever 84 (91.3)
Red swollen tonsils 74 (80.4)
Generalised body pain 67 (72.8)
Common cold Nasal discharge 84 (91.3)
Fever 71 (77.2)
Congestion 60 (65.2)
Sinusitis Headache 77 (83.7)
Congestion 69 (75.0)
Fever 55 (59.8)
AOM Pain in the ear 88 (95.7)
Fever 71 (77.2)
Hyperaemic ear drum 60 (65.2)
Reasons physicians (%) offered for antimicrobial overprescription in general practiceFigure 2
Reasons physicians (%) offered for antimicrobial overprescription in general practicePage 5 of 8
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with severe symptoms are at risk of bacterial
complications and prescribing antibiotics will prevent or
reduce such complications [23] a practice not encouraged
as effective prescribing strategy by the CDC [17]. Azithro-
mycin's use for all URTIs (except the common cold) war-
rants concern in light of increasing macrolide-resistant
pneumococci [24]. In sinusitis, cefuroxime use may point
towards a concern about lactamase producing Haemo-
philus influenzae infection in the community, and the use
of quinolones (11.1%) and tetracycline (14.9%) in chil-
dren is worrying.
Senior physicians practicing for >30 years would prescribe
antimicrobials for the common cold. In Hong Kong [25]
this practice characteristic was associated with inappropri-
ate prescribing for the common cold, and doctors
assumed patients expected antibiotics from them.
Younger doctors prescribe judiciously suggesting medical
curricula incorporate appropriate prescribing principles.
Emphasising rational pharmacotherapy in postgraduate
vocational training will heighten family practitioners'
competence on selective decisions on the need, choice
and duration of antimicrobials for URTIs.
The CDC does not recommend antimicrobials for pharyn-
gitis in the absence of undiagnosed Group A Streptococci
(GAS) where viral aetiology is generally prevalent, and
does not recognise tonsillitis as an independent URTI.
Penicillin V remains specifically recommended for phar-
yngitis, (expressly GAS infections which account for just
15% of all cases) particularly as GAS resistance to β-
lactams has not been documented [26]. The clinical pres-
entation of pharyngitis does not permit differentiation
between streptococcal and viral aetiology or reliably pre-
dict those who will benefit from antimicrobial therapy.
Untreated GAS uncommonly causes potentially fatal
rheumatic fever and physicians probably overestimate
streptococcal infection. Penicillin V, the recommended
antimicrobial for pharyngitis was never prescribed,
despite its safety, efficacy, narrow spectrum and low cost,
even though cost influenced GPs' prescribing.
Though doctors (50%) met the CDC recommendations
for AOM, existing research nonetheless, offers no compel-
ling evidence that outcomes are better in treated children
[27] and clinicians are advised to reconsider routine anti-
microbial use for AOM in children. Antimicrobial pre-
scribing for uncomplicated sinusitis with amoxicillin/
clavulanate (52.9%), azithromycin (25.3%) and amoxi-
cillin (25.3%), did not concur with the CDC guidelines,
which recommend narrow-spectrum antimicrobials for
10 days. Duration of therapy is as important a determi-
nant as dosage for success or failure of antimicrobial ther-
apy in paediatric patients, yet physicians widely
prescribed for 5–7 days for all URTIs.
High empirical antimicrobial prescribing (87.0%) pro-
vided evidence for physicians' reluctance for laboratory
investigations in private practice. Diagnostic uncertainty
prompted antimicrobial prescribing (58.7%) emphasis-
ing the CDC's recommendation for accessible laboratory
diagnosis with rapid reporting. We hasten to add such
counsel may be feasible in economically advanced coun-
tries with managed health care but remains to be accepted
by physicians and patients when cost is a crucial consider-
ation of treatment.
Declaring antibiotics are overused in general practice, doc-
tors (83.7%) offered parental expectation of receiving
antibiotics as the leading reason, yet only 7.6% in contrast
admitted this influenced their personal prescribing. In
California, physicians' perceptions of parental expecta-
tions for antimicrobials in conditions of presumed viral
aetiology were a significant predictor of prescribing anti-
microbials in community and university based paediatric
practices [28]. Patients and/or their parents reportedly
associated recovery with antimicrobial use and those phy-
sicians who met parental expectations of receiving an anti-
microbial believed a bacterial diagnosis was present. In
our study GPs perceived antimicrobials were more likely
to be prescribed when parents wanted them. Personal,
family or friends' experiences mould patient/parent
expectations [29] and pressure to fulfil these expectations
drives over prescribing.
Our data highlights the responsibility of pharmacists to
control antibiotic use and doctors' concern about this
accountability. Parimi et al [30] reported 19% of Trinidad
and Tobago's general public self-medicated with antimi-
crobials from private pharmacies, though these are con-
trolled 'prescription only medication' by the Food and
Drugs Division, Ministry of Health. The Pharmacy Board
and the Ministry of Health in the country are obliged to
monitor and enforce regulations for antimicrobial dis-
pensing in community pharmacies.
Our study has limitations. Responses were dependent on
the doctors' honesty and fidelity of recall. Time and busy
practices may have constrained doctors from seeking clar-
ifications on questions or giving detailed answers to open-
ended questions. There are no guidelines for antimicro-
bial prescribing in the Caribbean and we referred to
guidelines tailored for health care systems that do not
exist locally or regionally.
International guidelines for rational pharmacotherapy
have emerged following growing global concerns on
increasing multiple resistant strains of upper airway path-Page 6 of 8
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[16,17,31,32]. Reported low antimicrobial resistance in
the Netherlands, is attributed to Dutch family physicians
prescribing with relative restriction and selectivity for
URTIs. [33]. In Sicily, macrolides, cephalosporins, penicil-
lins with β-lactamase inhibitors and even extended spec-
trum penicillins were extensively prescribed by GPs for
URTIs and attributed to unavailability or non-awareness
of local or national guidelines [15]. Surveillance data
from The Caribbean Epidemiology Centre on local pat-
terns of pathogen susceptibility to antimicrobials can be
employed to develop regional guidelines. Prescribing
principles are nevertheless unlikely to evoke substantial
change unless their dissemination and promotion is sus-
tained through intensive continuing educational pro-
grammes for physicians and pharmacists. While
practitioners may be encouraged to recognize and contain
antimicrobial resistance, public educational campaigns
on symptomatic care, the expected course of illness, viral
aetiology of URTIs and the risks of inappropriate antimi-
crobial use will halt their misuse and encourage non-anti-
biotic strategies.
Conclusion
General practitioners in Trinidad preferentially prescribe
antimicrobials in children, for AOM, tonsillitis, sinusitis
and pharyngitis and their prescribing differed from the
CDC recommendations for each disease (except AOM) for
drug of choice and/or duration of prescription. Amoxicil-
lin is the preferred agent for all URTIs and penicillin V was
never recommended. GPs view parental pressure/expecta-
tions and secondary bacterial infections as determinants
for antimicrobial overprescription in paediatric URTIs.
Senior practitioners were more likely to prescribe antibi-
otics for the common cold. In the absence of local or
regional guidelines or data on resistance patterns in the
community, doctors remain unaware of appropriate pre-
scribing recommendations. Educational interventions for
parents and primary care providers can promote judicious
use of antimicrobials in this comparatively benign condi-
tion in the community and contain development of
resistance.
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